|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.80 EUR | +1.20% |
|
+8.59% | -7.40% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 20.13x | 4.03x | 3.25x | 3.88x | 15.28x | 18.27x | 1.64% | 3.42B | ||
| 35.7x | 21.69x | 0.78x | 12.68x | 26.75x | 27.72x | 0.57% | 1,067B | ||
| 28.24x | 7.17x | -1.83x | 6.45x | 17.87x | 19.41x | 2.04% | 635B | ||
| 33.87x | 12909.91x | 0.15x | 7.65x | 15.73x | 16.24x | 2.65% | 458B | ||
| 19.22x | 7.19x | 1.26x | 4.69x | 11.57x | 12.98x | 2.82% | 347B | ||
| 21.56x | 6.22x | -445.38x | 5.71x | 14.24x | 15.08x | 2.81% | 295B | ||
| 21.1x | 4.94x | 0.94x | 4.45x | 12.31x | 13.31x | 1.98% | 262B | ||
| 14.14x | 6.24x | -9.2x | 5.26x | 10.84x | 12.75x | 3.54% | 216B | ||
| 24.66x | 18.97x | 3.45x | 6.48x | 11.43x | 14.83x | 2.68% | 203B | ||
| -46.58x | 8.17x | 0.33x | 5.59x | 30.88x | 61.57x | 2.55% | 161B | ||
| 12.46x | 1.59x | 0.28x | 3.06x | 7.75x | 8.76x | 7.02% | 140B | ||
| 12.06x | 5.45x | 0.25x | 3.28x | 8.85x | 9.51x | 4.06% | 127B | ||
| 27.21x | 5.47x | 1.88x | 8.23x | 18.55x | 19.44x | -.--% | 121B | ||
| 11.44x | 1.21x | 2.97x | 2.16x | 6.92x | 7.86x | 5.6% | 104B | ||
| 12.1x | 4.42x | 0.97x | 2.71x | 7.84x | 8.96x | 3.63% | 102B | ||
| 24.15x | 5.43x | 1.47x | 8.05x | 15.24x | 15.99x | 1.84% | 74.54B | ||
| 45.97x | 1.22x | 65.49x | 2.77x | 9.8x | 28.48x | 3.62% | 55.09B | ||
| 38.33x | 5.12x | 2.11x | 8.65x | 28.71x | 30.01x | 0.5% | 52.08B | ||
| 19.91x | 1.61x | -0.12x | 1.69x | 8.02x | 13.47x | 0.49% | 51.52B | ||
| Average | 19.77x | 685.58x | -19.52x | 5.45x | 14.66x | 18.67x | 2.63% | 235.45B | |
| Weighted average by Cap. | 23.93x | 1,331.97x | -28.57x | 7.29x | 17.38x | 19.90x | 2.23% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















